Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

Mar 16, 2018

|

NEW YORK (GenomeWeb) – Foundation Medicine said today that it has partnered with Chugai Pharmaceutical, a member of the Roche Group, to broaden patient access to its cancer genomic profiling services in Japan.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Menu

Foundation Medicine, Chugai Partner to Bring Cancer Profiling Tests to Japan

To read the full story....

Breaking News

GenScript Biotech, IES Diagnostics Partner to Distribute SARS-CoV-2 Antibody Kit

NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date

RenalytixAI, Joslin Diabetes Center Ink Kidney Disease IP Agreement

Calciscon Raises $2.7M in Series A Round

PerkinElmer Preliminary Q1 Revenues Grow 98 Percent; FDA Issues EUA for PCR COVID-19 Test

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

A New Generation of PCR: At-home Testing and Preparing for Emerging Strains of COVID-19

What's Popular?

FDA-Led Group Evaluates Performance of RUO Liquid Biopsy Assays to Inform Practice Guidelines

Cofactor Genomics Begins Multi-Site Clinical Trial for Immunotherapy Prediction Assay

NantHealth Lands $137.5M in Financing to Extend Debt Maturity Date

Armed With $55M in New Funding, Nucleix to Further Invest in Early-Stage Lung Cancer Dx

Oncocyte AACR Data Expands Potential Applications for Immunotherapy Response Predictor

Sponsorships